中华哲学思维对肝癌治疗的启迪
Enlightenment of Chinese philosophic thinking on treatment of liver cancer
汤钊猷 . 中华哲学思维对肝癌治疗的启迪[J]. 外科理论与实践, 2022 , 27(02) : 93 -94 . DOI: 10.16139/j.1007-9610.2022.02.001
| [1] | Kelley RK. Atezolizumab plus bevacizumab—a landmark in liver cancer[J]. N Engl J Med, 2020, 382(20):1953-1955. |
| [2] | Zahalka AH, Frenette PS. Nerves in cancer[J]. Nat Rev Cancer, 2020, 20(3):143-157. |
| [3] | Gao X, Sanderson SM, Dai Z, et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism[J]. Nature, 2019, 572(7769):397-401. |
| [4] | Kanarek N, Petrova B, Sabatini DM. Dietary modifications for enhanced cancer therapy[J]. Nature, 2020, 579(7800):507-517. |
| [5] | Saeb-Parsy K, Wynn TA, Vallier L, et al. Plant-based and animal-based low-carbohydrate diets and risk of he-patocellular carcinoma among US men and women[J]. Hepatology, 2021, 73(1):175-185. |
| [6] | Zhang KZ, Zhang QB, Zhang QB, et al. Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model[J]. J Hematol Oncol, 2014, 7:28. |
| [7] | Loh SN. Arsenic and an old place: rescuing p53 mutants in cancer[J]. Cancer Cell, 2021, 39(2):140-142. |
| [8] | Liao SF, Koshiol J, Huang YH, et al. Postdiagnosis aspirin use associated with decreased biliary tract cancer-specific mortality in a large nationwide cohort[J]. He-patology, 2021, 74(4):1994-2006. |
| [9] | Choi J, Jo C, Lim YS. Tenofovir versus entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection[J]. Hepatology, 2021, 73(2):661-673. |
| [10] | Goh MJ, Sinn DH, Kim S, et al. Statin use and the risk of hepatocellular carcinoma in patients with chronic he-patitis B[J]. Hepatology, 2020, 71(6):2023-2032. |
| [11] | Prasad V. Our best weapons against cancer are not magic bullets[J]. Nature, 2020, 577(7791):451. |
| [12] | Zheng H, Pomyen Y, Hernandez MO, et al. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma[J]. Hepatology, 2018, 68(1):127-140. |
/
| 〈 |
|
〉 |
